Didier Tchetche
Declaration of interest
| Function | Company |
|---|---|
| None |
Latest contributions
Highlights of science and education in cardiovascular interventional medicine in 2025
22 Dec 2025
Dear Colleagues, dear PCR Companions,
As we welcome a New Year, it is the perfect time to reflect on what we achieved together over the past year - both as a celebration of our collective success and as motivation to continue improving in the year ahead.
2025 was...
Complex valve-in-valve leaflet modification - LIVE case
17 Nov 2025 – From PCR London Valves 2025
Delve into a complex valve-in-valve leaflet modification through a LIVE educational case from Clinique Pasteur, Toulouse, complemented by expert analysis and a recorded case from Erasmus University Medical Center, Rotterdam. This session presents patient imaging, operator strategy, and detailed procedural insights that enhance understanding of advanced...
Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice
17 Nov 2025 – From PCR London Valves 2025
Discover the essential takeaways from the Myval THV series for improving TAVI outcomes. Learn from high-volume operators how pre-procedural planning, imaging, and sizing rationale guide optimal patient management. See step-by-step implantation of the next-gen Myval Octapro+, including the OctaAlign technique, and understand how precise deployment and...
Planning a lifetime of care in younger patients with Evolut FX+: from index valve to future options
17 Nov 2025 – From PCR London Valves 2025
Watch this PCR London Valves 2025 session to take a deep look at the latest evidence in low-risk aortic stenosis, the durability of contemporary valves, and how anatomy — especially in women and patients with small annuli — shapes long-term strategy.
From index TAVI with Evolut FX+...
Special Recognition Award Ceremony
17 Nov 2025 – From PCR London Valves 2025
The Special Recognition Award Ceremony honors outstanding achievements and contributions within the field of cardiology. This distinguished event celebrates excellence, innovation, and dedication, acknowledging individuals and teams who have significantly advanced interventional cardiology and patient care.
Mitral TEER and LAA closure - LIVE case
17 Nov 2025 – From PCR London Valves 2025
This educational session presents a live case from Clinique Pasteur, Toulouse, France, focusing on Mitral Transcatheter Edge-to-Edge Repair (TEER) combined with Left Atrial Appendage (LAA) closure. Attendees gain insights into patient evaluation, operator strategies, device selection, and procedural execution, complemented by a recorded case from Upper...
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
Mitral TEER - LIVE case
16 Nov 2025 – From PCR London Valves 2025
This live educational case from Hospital Álvaro Cunqueiro in Vigo, Spain, offers an in-depth look at Mitral TEER, including patient presentation, imaging analysis, operator strategy, and device overview. The session also features a recorded case from the Heart and Diabetes Center NRW in Germany, providing comprehensive...
PCR London Valves 2025 Welcome Ceremony
16 Nov 2025 – From PCR London Valves 2025
The PCR London Valves 2025 Welcome Ceremony marks the commencement of the conference, setting the stage for an immersive exploration of the latest advances and innovations in valvular heart disease management with a focus on transcatheter interventions.
TAVI in challenging scenarios, diving into real-life cases
12 Sep 2025 – From PCR Rio Valves 2025
Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
Expanding horizons with balloon-expandable TAVI - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 76-year-old male with a history of abdominal and iliac stent grafts (2022), severe COPD, prostate cancer, and gastric ulcer presented with symptomatic severe aortic stenosis. CT and echocardiography showed a calcified bicuspid aortic valve with preserved LV function.
A 24.5 mm Myval valve was implanted without...
Precision in mitral TEER
11 Sep 2025 – From PCR Rio Valves 2025
Join this live educational session from Bordeaux University Hospital to gain expert insights into mitral transcatheter edge-to-edge repair (TEER). Explore optimal timing and clinical decision-making for mitral regurgitation treatment, and discover how the PASCAL Precision system enhances procedural precision across diverse mitral anatomies. Witness real-time strategies,...
Valve-in-valve and coronary protection
11 Sep 2025 – From PCR Rio Valves 2025
Explore complex valve-in-valve procedures and coronary protection strategies through a series of challenging case presentations. Topics include management of high-risk valve-in-valve scenarios, strategies for degenerated aortic bioprostheses, innovative transcarotid approaches, fenestration stenting for late coronary obstruction, and analysis of valve embolisation events, providing valuable insights for...
Welcome to PCR Rio Valves 2025
11 Sep 2025 – From PCR Rio Valves 2025
Watch the opening ceremony of the very first edition of PCR Rio Valves! Experience the excitement as this inaugural 2-day Course kicks off. Hear introductions in English, Portuguese, and Spanish, meet the Course Directors, Programme Committee, and Faculty, explore the rich program in detail, and get...
Tailored transfemoral TAVI in complex anatomies - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Medtronic
An 89-year-old male with hypertension, dyslipidemia, current smoking, stage III kidney disease, and a history of diagonal PCI in 2010 presented with severe symptomatic aortic stenosis and a small annulus (410 mm²), with RBBB on ECG.
Via bilateral femoral access,...
Step-by-step TAVI procedure in Europe and India - A review from PCR and India Valves
24 Jul 2025
Watch this replay with A.B. Gopalamurugan, B. Prendergast, G. Sengottuvelu and D. Tchetche and discuss the current state of valvular interventions globally and in India, and so much more!
Learnings from LANDMARK and Compare-TAVI at 3 years
22 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Andreas Baumbach, Christian Juhl Terkelsen and Didier Tchetche reviewed the latest findings from the LANDMARK and Compare-TAVI 1 trials—both focused on the performance of the Myval balloon-expandable valve.
LANDMARK compared Myval and Myval Octacor to leading self-expanding valves in a randomised controlled trial. At...
How to manage the challenges of TAVI in bicuspid disease?
22 May 2025 – From EuroPCR 2025
How should TAVI be adapted to the unique challenges of bicuspid aortic valve disease? In this EuroPCR 2025 discussion, Chiara De Biase, Kentaro Hayashida, and Didier Tchetche explore the key anatomical and procedural considerations for tailoring treatment. From selecting which bicuspid anatomies are suitable for TAVI...
Learnings from Evolut Low Risk 5-year and SMART 2-year trials : from evidence to practice
21 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Angela McInerney, Didier Tchétché, and Ole De Backer discuss key results from the SMART and Evolut Low Risk trials. The SMART trial compared balloon-expandable and self-expanding valves in small annulus patients, showing better hemodynamics with the Evolut platform at 2 years. The Evolut...
Overcoming anatomical challenges in the lifetime management of young TAVI patients
27 Mar 2025
Watch this replay with D. Tchetche, S. Bleiziffer, D. Dvir and D. Talreja and learn about the criteria for valve selection before TAVI in young patients, and so much more!
International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer
08 Mar 2025
It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...
Author
Aortic Stenosis in Women: causes, symptoms and treatment options
06 Mar 2025
The patient booklets on this page aim to help women get a better understanding of the condition, recognize symptoms, and explore options to get the right care at the right time.
PCR Tokyo Valves 2025 Closing Ceremony
09 Feb 2025 – From PCR Tokyo Valves 2025
Join us for the powerful closing ceremony of PCR Tokyo Valves 2025, following a course that gathered 1,200 participants. Watch the winner of the best clinical case present his complex case of severe aortic stenosis, left main coronary artery dissection, and severe primary mitral regurgitation in...
Transcatheter management of failed THV - LIVE case
Recommended by PCR
09 Feb 2025 – From PCR Tokyo Valves 2025
An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...
Indication and device selection for tricuspid interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to sharpen your skills in selecting the right patients and devices for transcatheter tricuspid interventions? Don’t miss this session!
Learn how to assess anatomical suitability for T-TEER and TTVR, identify patients who may benefit from replacement over repair and explore the latest insights on timing and...
More possibilities in TEER - Treatment of degenerative mitral regurgitation
09 Feb 2025 – From PCR Tokyo Valves 2025
Through case reviews, explore the latest advancements in transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation. Discover how a novel TEER device expands treatment possibilities, offering predictable and durable results.
Valve in valve in small degenerative surgical bioprosthesis - LIVE case
09 Feb 2025 – From PCR Tokyo Valves 2025
A 74-year-old female with a permanent pacemaker and preserved LV function presented with a symptomatic degenerative surgical valve (SJ Epic 21) implanted in 2016.
Patient underwent implantation of an Evolut FX 26 mm under general anesthesia with cerebral embolic protection and TEE guidance. A surgical valve fracture...
TAVI in small annulus - LIVE case
08 Feb 2025 – From PCR Tokyo Valves 2025
A 79-year-old female with CAD (stenosis in the mid-LAD), asthma, and diabetes presented with symptomatic severe aortic stenosis. Left ventricular function was preserved, with an annulus measuring 355 mm², and the valves were heavily calcified.
A Navitor Vision valve was implanted with predilatation (18 mm balloon) under...
Future devices for structural heart interventions
08 Feb 2025 – From PCR Tokyo Valves 2025
Get a glimpse into the future of structural heart interventions! This PCR Tokyo Valves 2025 session dives into the latest innovations in imaging and explores groundbreaking devices for mitral and tricuspid valve treatments. Watch as experts discuss how these advancements are set to reshape clinical practice.
